- Home
- CMMB vs YFOR Comparison
CMMB vs YFOR Comparison
Compare CMMB & YFOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.58
N/A
Current Price
$1.26
Company Overview
Basic Information| Metric | CMMB | YFOR |
|---|---|---|
| Founded | 2004 | N/A |
| Country | Israel | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9M | 18.4M |
| IPO Year | 2023 | 2023 |
Fundamental Metrics
Financial Performance| Metric | CMMB | YFOR |
|---|---|---|
| Price | $2.58 | $1.26 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | 104.2K | ★ 212.6K |
| Earning Date | 05-21-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.67 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $67.25 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.35 | $1.31 |
| 52 Week High | $3.55 | $1.53 |
Technical Indicators
Market Signals| Indicator | CMMB | YFOR |
|---|---|---|
| Relative Strength Index (RSI) | 65.37 | N/A |
| Support Level | $1.49 | N/A |
| Resistance Level | $2.86 | N/A |
| Average True Range (ATR) | 0.22 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 62.13 | 0.00 |
Price Performance
Historical Comparison CMMB
YFOR
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.